Gilead Sciences (GILD) Acquisitions (2011 - 2026)
Gilead Sciences' (GILD) quarterly Acquisitions came in at $109.0 million in Q1 2026, down 60.07% YoY from $273.0 million in Q1 2025, and down 82.1% on a QoQ basis from $609.0 million in Q4 2025.
Gilead Sciences (GILD) Acquisitions (2011 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 10 years of Acquisitions data on file, last reported at $109.0 million in Q1 2026.
- Quarterly Acquisitions fell 60.07% year-over-year to $109.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $906.0 million (down 15.33% YoY) and the FY2025 annual result came in at $1.1 billion, down 77.89% from the prior year.
- Acquisitions fell to $109.0 million in Q1 2026, from $609.0 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $4.0 billion in Q1 2024 to a low of $21.0 million in Q2 2025.
- A 5-year average of $527.5 million and a median of $273.0 million in 2025 frame the typical range for Acquisitions.
- The widest YoY moves for Acquisitions: up 712.0% in 2025, down 93.25% in 2025.
- Tracing GILD's Acquisitions over 5 years: stood at $218.0 million in 2022, then gained by 27.98% to $279.0 million in 2023, then sank by 73.12% to $75.0 million in 2024, then surged by 712.0% to $609.0 million in 2025, then sank by 82.1% to $109.0 million in 2026.
- The last three Acquisitions figures came in at $109.0 million (Q1 2026), $609.0 million (Q4 2025), and $167.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | -17.24 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | - |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | - |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 11.21 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | - |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.21 Bn |
| Mar 31, 2026 | 109.00 Mn |
| Dec 31, 2025 | 609.00 Mn |
| Sep 30, 2025 | 167.00 Mn |
| Jun 30, 2025 | 21.00 Mn |
| Mar 31, 2025 | 273.00 Mn |
| Dec 31, 2024 | 75.00 Mn |
| Sep 30, 2024 | 570.00 Mn |
| Jun 30, 2024 | 152.00 Mn |
| Mar 31, 2024 | 4.04 Bn |
| Dec 31, 2023 | 279.00 Mn |
| Sep 30, 2023 | 79.00 Mn |
| Jun 30, 2023 | 243.00 Mn |
| Mar 31, 2023 | 551.00 Mn |
| Dec 31, 2022 | 218.00 Mn |
| Sep 30, 2022 | 448.00 Mn |
| Jun 30, 2022 | 324.00 Mn |
| Mar 31, 2022 | 807.00 Mn |
| Dec 31, 2021 | 44.00 Mn |
| Sep 30, 2021 | 83.00 Mn |